Led by a team of global myeloma experts, the Black Swan Research Initiative coordinates and supports more than 40 global research projects. Learn about the BSRI Team Leaders and the countries they represent.

Black Swan Research Initiative Team

Team Leaders

	Brian G.M. Durie, MD Co-Founder and Board Member International Myeloma Foundation North Hollywood, California
	Prof. Jesús San Miguel, MD Director of Clinical and Translational Medicine University of Navarra Pamplona, Spain
	S. Vincent Rajkumar, MD Professor of Medicine and Chair of the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group Rochester, Minnesota

Iceland

	Sigurdur Kristinsson, MD University of Iceland Reykjavík, Iceland
	Stephen Harding, PhD Research and Development Director The Binding Site Birmingham, United Kingdom
	Kelly Endean Head of Medical Science Liaison - Monoclonal Gammopathy The Binding Site Birmingham, United Kingdom
	Sæmundur Rögnvaldsson Researcher University of Iceland Reykjavík, Iceland
	Ásdís Rósa Þórðardóttir Project Manager University of Iceland Reykjavík, Iceland

Spain

	Prof. Jesús San Miguel, MD Director of Clinical and Translational Medicine University of Navarra Pamplona, Spain
	Bruno Paiva, MD, PhD University of Navarra Pamplona, Spain
	María-Victoria Mateos, MD, PhD University of Salamanca Salamanca, Spain
	Alberto Orfao, MD, PhD Department of Medicine, Cancer Research Center University of Salamanca Salamanca, Spain

Germany

Hartmut Goldschmidt, MD
Professor of Medicine (Hematology and Oncology) and Head of the Multiple Myeloma Program
University Hospital Heidelberg
Heidelberg, Germany

Jens Hillengass, MD*
University of Heidelberg
Heidelberg, Germany

*Now moved to Roswell Park Cancer Center, Buffalo, New York

Australia

Andrew Spencer, MD
Head of the Malignant Haematology & Stem Cell Transplantation Service
The Alfred Hospital
Professor
Monash University
Melbourne, Australia

France

	Hervé Avet-Loiseau, MD Head of the Laboratory for Genomics in Myeloma University of Toulouse Toulouse, France
	Philippe Moreau, MD University Hospital Nantes, France

United States

	Brian G.M. Durie, MD Co-Founder and Board Member International Myeloma Foundation North Hollywood, California
	Suzanne Lentzsch, MD, PhD Associate Professor of Medicine and Director of the Multiple Myeloma and Amyloidosis Program Columbia University and at New York Presbyterian Hospital New York, New York
	Saad Usmani, MD Director of Clinical Research (Hematologic Malignancies), Director of Plasma Cell Disorders Levine Cancer Institute, Carolinas Healthcare System Charlotte, North Carolina

I2TEAMM for FDA Submission

	Brian G.M. Durie, MD Co-Founder and Board Member International Myeloma Foundation North Hollywood, California
	Shaji Kumar, MD Professor of Medicine, Hematology Mayo Clinic Rochester, Minnesota
	Nikhil Munshi, MD Professor of Medicine, Harvard Medical School Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute Boston, Massachusetts
	S. Vincent Rajkumar, MD Professor of Medicine and Chair of the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group Rochester, Minnesota
	Prof. Jesús San Miguel, MD Director of Clinical and Translational Medicine University of Navarra Pamplona, Spain
	Qian Shi, PhD Associate Professor of Biostatistics and Senior Associate Consultant Division of Biomedical Statistics and Informatics, Department of Health Sciences Research Mayo Clinic Rochester, Rochester, MN
	Philip McCarthy, MD Professor of Oncology and Internal Medicine Director, Blood and Marrow Transplant Center Roswell Park Cancer Institute Buffalo, New York
	Paul Wallace, PhD Professor of Oncology Director, Department of Flow & Image Cytometry Roswell Park Cancer Institute Buffalo, New York
	Theresa (Terri) Hahn, PhD Professor of Oncology Cancer Prevention and Population Sciences CCSG Program Roswell Park Cancer Institute Buffalo, New York
	Joseph (Joe) Tario Jr., PhD Senior Flow Cytometry Specialist Department of Flow & Image Cytometry Roswell Park Cancer Institute Buffalo, New York
	Marcelo Pasquini, MD Associate Professor of Medicine Scientific Director Center for International Blood and Marrow Transplant Research Medical College of Wisconsin Milwaukee, Wisconsin
	Edward Stadtmauer, MD Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor Section Chief, Hematologic Malignancies University of Pennsylvania School of Medicine Philadelphia, Pennsylvania
	Hartmut Goldschmidt, MD Professor of Medicine (Hematology and Oncology) and Head of the Multiple Myeloma Program University Hospital Heidelberg Heidelberg, Germany
	Dirk Hose, MD Head of the Multiple Myeloma Research Laboratory, Department of Internal Medicine University of Heidelberg Heidelberg, Germany
	Stefanie Huhn, PhD Department Head of the Multiple Myeloma Research Laboratory University of Heidelberg Heidelberg, Germany
	Hervé Avet-Loiseau, MD Head of the Laboratory for Genomics in Myeloma University of Toulouse Toulouse, France
	Philippe Moreau, MD University Hospital Nantes, France
	Michel Attal, MD General Director Institut Universitaire du Cancer de Toulouse-Oncopole Toulouse, France
	Andy Rawstron, PhD Department of Hematology St. James's University Hospital Leeds, United Kingdom
	Roger Owen, MD Consultant Hematologist St. James's University Hospital Leeds, United Kingdom
	Mario Boccadoro, MD Professor University of Torino Torino, Italy
	Stefania Oliva, MD Myeloma Unit, Division of Hematology University of Torino Torino, Italy
	Prof. Pieter Sonneveld, MD Head of the Department of Hematology Erasmus MC Cancer Institute, Rotterdam The Netherlands
	Shaji Kumar, MD Professor of Medicine, Hematology Mayo Clinic Rochester, Minnesota
	Kenneth (Ken) Anderson, MD Kraft Family Professor of Medicine, Harvard Medical School Physician, Oncology, Brigham And Women's Hospital Dana-Farber Cancer Institute Boston, Massachusetts

CESAR Trial

	María-Victoria Mateos, MD, PhD Director of the Myeloma Unit University Hospital of Salamanca Salamanca, Spain
	Prof. Alberto Orfao, MD, PhD Department of Medicine, Cancer Research Center University of Salamanca Salamanca, Spain
	Bruno Paiva, MD, PhD University of Navarra Pamplona, Spain
	Prof. Jesús San Miguel, MD Director of Clinical and Translational Medicine University of Navarra Pamplona, Spain
	Joan Bladé, MD Hospital Clínica de Barcelona Barcelona, Spain
	Juan José Lahuerta, MD Hospital Universitario 12 de Octubre Madrid, Spain

ASCENT Trial

	Brian G.M. Durie, MD Co-Founder and Board Member International Myeloma Foundation North Hollywood, California
	Shaji Kumar, MD Professor of Medicine, Hematology Mayo Clinic Rochester, Minnesota

Global MRD Consortium

	Wee-Joo Chng, MD, PhD Professor, Yong Loo Lin School of Medicine, National University of Singapore Associate Director, Research, National University Cancer Institute, Singapore Deputy Director, Cancer Science Institute of Singapore, National University of Singapore
	Meletios Dimopoulos, MD Professor and Chairman of the Department of Clinical Therapeutics University Athens School of Medicine Athens, Greece
	Juan Du, MD Changzhen Hospital Shanghai, China
	Roman Hajek, MD, PhD Professor University Hospital Brno and Masaryk University Brno, Czech Republic
	Heinz Ludwig, MD Professor Wilhelminenspital Wien, Austria
	Hareth Nahi, MD Associate Professor Karolinska University Hospital Stockholm, Sweden
	Evangelos Terpos, MD, PhD Hematologist University Athens School of Medicine Athens, Greece